Thursday 21 May 2020

MARKET LIVE: Sensex, Nifty recoup losses ahead of RBI press meet; RIL up 1%

Indian markets erased the entire opening losses on Friday ahead of the 10 AM press conference by Reserve Bank of India (RBI) Governor Shaktikanta Das.
Among headline indices, the S&P BSE Sensex was up 40 points at around 30,970 levels and the Nifty50 index reclaimed the 9,100 mark. Infosys gained 2 per cent after the class action lawsuit filed against the company in the US was dismissed. Reliance Industries gained 1 per cent after the conglomerate said that KKR would invest Rs 11,367 crore into Jio Platforms for 2.32 per cent equity stake. READ MORE
The trends among Nifty sectoral indices was mixed. Nifty PSU Bank index, up 1.8 per cent, gained the most.
Results today

A total of 25 companies including Alembic Pharmaceuticals, IDFC First Bank, and UPL, are scheduled to announce their March quarter earnings later in the day.
CATCH ALL THE LIVE UPDATES
Auto Refresh
09:44 AM
NIIT Tech surges over 3% on buyback proposal
>> Co said its Rs 337.4-crore buyback offer will commence from May 29.

09:40 AM
Aviation stocks in focus; govt caps air fares for three months
>> Domestic flights to resume from Monday, May 25

09:36 AM
SECTOR ALERT :: Nifty PSU Bank index trades as top gainer on NSE
09:34 AM
MARKET CHECK
09:33 AM
MARKET CHECK :: Indices pare losses
09:32 AM
RIL gains 1% as KKR picks up 2.32% stake for Rs 11,367 cr in Jio Platforms
Again, this deal showcases interest of global investors in Jio Platforms. Further, along with the previous four deals this deal could help RJio in realisation of its digital plans. Over the last month, leading technology investors, such as, Facebook, Silver Lake, Vista, General Atlantic and KKR have announced aggregate investments of Rs 78,562 crore into Jio Platforms. READ MORE

09:30 AM
Financials trade mixed ahead of RBI Guv media address
>> PFC, HDFC Bank, Axis Bank, down 1-2 per cent, are top losers on the index
>> Edelweiss, Cholamandalam Finance, SBI, and M&M Fin, up 1-3 per cent, are top gainers

09:27 AM
Strides Pharma advances 1%
>> Strides Pharma Science has got approval from the Drug Controller General of India (DCGI) to conduct trials of antiviral drug Favipiravir in India, which is considered a potential treatment for Covid-19.

>> “We have the approval to conduct human study and we will be starting the trials soon in India,” the Bengaluru-based company said on Thursday.
09:24 AM
SBI off lows, up nearly 1%
09:23 AM
Result Impact | VST Industries jumps over 3%
>> Net profit of VST Industries rose 33.15 per cent to Rs 70.61 crore in the quarter ended March 2020 as against Rs 53.03 crore in the previous year quarter.

No comments:

Post a Comment